Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Oral Epigallocatechin Gallate Treatment for Low-grade Cervical Lesions (L-SIL) Associated With Human Papilloma Virus (HPV) Infection

NCT06314113 is registered in ClinicalTrials.gov with University of Palermo as lead sponsor.

NCT NCT06314113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06314113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Oral Epigallocatechin Gallate Treatment for Low-grade Cervical Lesions (L-SIL) Associated With Human Papilloma Virus (HPV) Infection
Lead sponsor
University of Palermo
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2024
Completion date
September 1, 2025
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

low-grade intraepithelial neoplasia of cervix